{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:14:51Z","timestamp":1789874091162,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Avis and Clifford Barrus Medical Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.neulet.2016.03.051","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T13:15:17Z","timestamp":1459170917000},"page":"70-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Antidepressant-like effect of low dose ketamine and scopolamine co-treatment in mice"],"prefix":"10.1016","volume":"620","author":[{"given":"Tracey L.","family":"Petryshen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Dennehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob C.","family":"Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Fava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2016.03.051_bib0005","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","article-title":"Diagnosis and definition of treatment-resistant depression","volume":"53","author":"Fava","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.03.051_bib0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.03.051_bib0015","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.03.051_bib0020","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2016.03.051_bib0025","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2016.03.051_bib0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","author":"aan het Rot","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.03.051_bib0035","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archpsyc.63.10.1121","article-title":"Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized placebo-controlled clinical trial","volume":"63","author":"Furey","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2016.03.051_bib0040","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biopsych.2009.11.021","article-title":"Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized placebo-controlled clinical trial","volume":"67","author":"Drevets","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.03.051_bib0045","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.biopsych.2012.03.029","article-title":"Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression","volume":"72","author":"Cornwell","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.03.051_bib0050","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/2013.jamapsychiatry.60","article-title":"Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder","volume":"70","author":"Furey","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neulet.2016.03.051_bib0055","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","article-title":"Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus","volume":"32","author":"Garcia","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.03.051_bib0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2016.03.051_bib0065","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neulet.2016.03.051_bib0070","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-3223(01)01083-6","article-title":"Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication","volume":"50","author":"Chen","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.03.051_bib0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.08.044","article-title":"Signaling pathways underlying the rapid antidepressant actions of ketamine","volume":"62","author":"Duman","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2016.03.051_bib0080","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.biopsych.2012.09.006","article-title":"The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine","volume":"73","author":"Monteggia","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.03.051_bib0085","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/mp.2011.47","article-title":"Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice","volume":"16","author":"Beurel","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.03.051_bib0090","first-page":"400","article-title":"Effect of scopolamine on depression in mice","volume":"46","author":"Ji","year":"2011","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.neulet.2016.03.051_bib0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0014-2999(88)90067-2","article-title":"Cholinergic drug effects on antidepressant-induced behaviour in the forced swimming test","volume":"158","author":"Mancinelli","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2016.03.051_bib0100","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.biopsych.2013.04.025","article-title":"Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses","volume":"74","author":"Voleti","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.03.051_bib0105","first-page":"95","article-title":"Muscarinic receptors modulate the mRNA expression of NMDA receptors in brainstem and the release of glutamate in periaqueductal grey during morphine withdrawal in rats","volume":"56","author":"Liu","year":"2004","journal-title":"Sheng Li Xue Bao"},{"key":"10.1016\/j.neulet.2016.03.051_bib0110","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00442247","article-title":"Discovery of antidepressant activity by forced swimming test may depend on pre-exposure of rats to a stressful situation","volume":"97","author":"Borsini","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2016.03.051_bib0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology"},{"issue":"59","key":"10.1016\/j.neulet.2016.03.051_bib0120","first-page":"e3638","article-title":"The mouse forced swim test","author":"Can","year":"2012","journal-title":"J. Vis. Exp.: JoVE"},{"key":"10.1016\/j.neulet.2016.03.051_bib0125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbr.2014.11.016","article-title":"Dopamine D2\/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test","volume":"279","author":"Li","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2016.03.051_bib0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2016.03.051_bib0135","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbr.2015.04.002","article-title":"Ventral tegmental area cholinergic mechanisms mediate behavioral responses in the forced swim test","volume":"288","author":"Addy","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2016.03.051_bib0140","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature11740","article-title":"Dopamine neurons modulate neural encoding and expression of depression-related behaviour","volume":"493","author":"Tye","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2016.03.051_bib0145","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11713","article-title":"Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons","volume":"493","author":"Chaudhury","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2016.03.051_bib0150","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1124\/jpet.114.216804","article-title":"M1 and m2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamine","volume":"351","author":"Witkin","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2016.03.051_bib0155","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00213-002-1004-7","article-title":"Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats","volume":"161","author":"Nelson","year":"2002","journal-title":"Psychopharmacology"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016301975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016301975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T23:04:50Z","timestamp":1556492690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394016301975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":31,"alternative-id":["S0304394016301975"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2016.03.051","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant-like effect of low dose ketamine and scopolamine co-treatment in mice","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2016.03.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}